Envelope structure and the development of new vaccines
1993; Wiley; Volume: 74; Issue: S22 Linguagem: Inglês
10.1111/j.1365-2672.1993.tb04341.x
ISSN2056-5232
Autores Tópico(s)Microbial infections and disease research
ResumoJournal of Applied BacteriologyVolume 74, Issue S22 p. 43S-51S Envelope structure and the development of new vaccines A. Robinson, Corresponding Author A. Robinson Division of Biologics, PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire, UKDivision of Biologics, PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire SP40JG, UK.Search for more papers by this authorJ. Melling, J. Melling Division of Biologics, PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire, UKSearch for more papers by this author A. Robinson, Corresponding Author A. Robinson Division of Biologics, PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire, UKDivision of Biologics, PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire SP40JG, UK.Search for more papers by this authorJ. Melling, J. Melling Division of Biologics, PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire, UKSearch for more papers by this author First published: June 1993 https://doi.org/10.1111/j.1365-2672.1993.tb04341.xCitations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Achtman, M., Wall, R.A., Bopp, M., Kusecek, B., Morelli, G., Saken, E. and Hassan-King, M. (1991) Variation in Class 5 protein expression by serogroup A meningococci during a meningitis epidemic. Journal of Infectious Diseases 164, 375–382. 10.1093/infdis/164.2.375 CASPubMedWeb of Science®Google Scholar Agterberg, M., Adriaanse, H., Lankhof, H., Meloen, R. and Tommassen, J. (1990) Outer membrane PhoE protein of Escherichia coli as a carrier for foreign antigenic determinants: immunogenicity of epitopes of foot-and-mouth disease virus. Vaccine 8, 85–91. 10.1016/0264-410X(90)90184-N CASPubMedWeb of Science®Google Scholar Aho, E.L., Dempsey, J.A., Hobbs, M.M., Klapper, D.G. and Cannon, J.G. (1991) Characterization of the opa (Class 5) gene family of Neisseria meningitidis. Molecular Microbiology 5, 1429–1437. 10.1111/j.1365-2958.1991.tb00789.x CASPubMedWeb of Science®Google Scholar Ala'aldeen, D.A., Wall, R.A. and Borriello, S.P. (1990) Immunogenicity and cross-reactivity of the 70-kDa iron-regulated protein of Neisseria meningitidis in man and animals. Journal of Medical Microbiology 32, 275–281. 10.1099/00222615-32-4-275 CASPubMedWeb of Science®Google Scholar Anon. (1991) NIPH Annals. Oslo : National Institutes of Public Health. Google Scholar Bakker, D., van Zijderveld, F.C., van der Veen, S., Oudega, B. and de Graaf, F.K. (1990) K88 fimbriae as carriers of heterologous antigenic determinants. Microbial Pathogenesis 8, 343–352. 10.1016/0882-4010(90)90093-6 CASPubMedWeb of Science®Google Scholar Bhattacharjee, A.K., Moran, E.E. and Zollinger, W.D. (1989) Antibodies to meningococcal H.8 (Lip) antigen fail to show bactericidal activity. Canadian Journal of Microbiology 36, 117–122. 10.1139/m90-021 Web of Science®Google Scholar Coote, J.G. (1991) Antigenic switching and pathogenicity: environmental effects on virulence gene expression in Bordetella pertussis. Journal of General Microbiology 137, 2493–2503. 10.1099/00221287-137-11-2493 CASPubMedWeb of Science®Google Scholar Finlay, B.B. and Falkow, S. (1989) Common themes in microbial pathogenicity. Microbiological Reviews 53, 210–230. 10.1128/mr.53.2.210-230.1989 CASPubMedWeb of Science®Google Scholar Fox, A.J., Borrow, R. and Jones, D.M. (1991) A western blot analysis of Neisseria antigens reactive with sera from cases and carriers of Neisseria meningitidis. In Neisseria 1990 ed. M. Achtman, P. Kohl, C. Marchal, G. Morelli, A. Seiler and B. Thiesen pp. 205–207. Berlin : Walter de Gruyter. Web of Science®Google Scholar Frasch, C.E. (1989) Vaccines for prevention of meningococcal disease. Clinical Microbiological Reviews, 2 Supplement, S134–S138. Google Scholar Griffith, E., Stevenson, P. and Ray, A. (1990) Antigenic and molecular heterogeneity of the transferrin-binding protein of Neisseria meningitidis. FEMS Microbiology Letters 69, 31–36. 10.1111/j.1574-6968.1990.tb04170.x Web of Science®Google Scholar Hambleton, P., Prior, S.D. and Robinson, A. (1988) Approaches to the rational design of bacterial vaccines. In Progress in Drug Research, Vol. 32, ed. E. Jucker pp. 377–409. Basel : Birkhauser Verlag. Google Scholar Heckels, J.E. (1989) Structure and function of pili from pathogenic Neisseria species. Clinical Microbiological Reviews 2 Supplement, S66–S73. Google Scholar Hedegaard, L. and Klem, P. (1989) Type 1 fimbriae of Escherichia coli as carriers of heterologous antigenic sequences. Gene 85, 115–124. 10.1016/0378-1119(89)90471-X CASPubMedWeb of Science®Google Scholar Hewlett, E.L. and Cherry, J.D. (1990) New improved vaccines against pertussis. In New Generation Vaccines ed. G.C. Woodrow and M.M. Levine pp. 231–250. New York : Marcel Dekker. Google Scholar Jennings, H.J., Gamian, A., Michon, F. and Ashton, F.E. (1989) Unique intermolecular bactericidal epitope involving the homo-sialopolysaccharide capsule of the cell surface of group B Neisseria meningitidis and Escherichia coli K1. Journal of Immunology 142, 3585–3591. CASPubMedWeb of Science®Google Scholar Kimura, A., Mountzouros, K.T., Relman, D.A., Falkow, S. and Cowell, J.L. (1990) Bordetella pertussis filamentous haemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infection and Immunity 58, 7–16. CASPubMedWeb of Science®Google Scholar Klein, D. (1991) A Phase II multicenter evaluation of several candidate pertussis vaccines in infants. Development of Biological Standardization 73, 305–309. CASPubMedWeb of Science®Google Scholar Leclerc, C., Charbit, A., Martineau, P., Deriaud, E. and Hofnung, M. (1991) The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics. Journal of Immunology 147, 3545–3552. CASPubMedWeb of Science®Google Scholar Leininger, E., Roberts, M., Kenimer, J.G., Charles, I.G., Fairweather, N., Novotny, P. and Brennan, M.J. (1991) Pertactin, an arg-gly-asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proceedings of the National Academy of Science USA 88, 345–349. 10.1073/pnas.88.2.345 CASPubMedWeb of Science®Google Scholar Lifely, M.R., Roberts, S.C., Shepherd, W.M., Esdaile, J., Wang, Z., Cleverly, A., Aulaqi, A.A. and Moreno, C. (1991) Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complex with outer membrane proteins. Vaccine 9, 60–66. 10.1016/0264-410X(91)90318-Z CASPubMedWeb of Science®Google Scholar McGuinness, B., Barlow, A.K., Clarke, I.N., Farley, J.E., Anilionis, A., Poolman, J.T. and Heckels, J.E. (1990) Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Journal of Experimental Medicine 171, 1871–1882. 10.1084/jem.171.6.1871 CASPubMedWeb of Science®Google Scholar McGuinness, B., Clarke, I.N., Lambden, P.R., Barlow, A.K., Poolman, J.T., Jones, D.M. and Heckels, J.E. (1991) Point mutation in meningococcal por A gene associated with increased endemic disease. Lancet 337, 514–517. 10.1016/0140-6736(91)91297-8 CASPubMedWeb of Science®Google Scholar Maiden, M.C.J., Suker, J., McKenna, A.J., Bygraves, J.A. and Feavers, I.M. (1991) Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis. Molecular Microbiology 5, 727–736. 10.1111/j.1365-2958.1991.tb00743.x CASPubMedWeb of Science®Google Scholar Miller, E., Miller, D.L., Ashworth, L.A.E., Waight, P.A. and Harbert, K.A. (1990) Preliminary comparison of antibody responses and symptoms following primary immunization with British whole-cell and three acellular DTP vaccines. In Proceedings of the Sixth International Symposium on Pertussis, ed. C.R. Manclark pp. 303–310. Department of Health and Human Services, US Public Health Service, Bethesda, Maryland. DHHS Publication Number (FDA) 90–1164. Google Scholar Miller, E., Ashworth, L.A.E., Robinson, A., Waight, P.A. and Irons, L.I. (1991) Phase II trial of whole cell pertussis vaccine vs an acellular vaccine containing agglutinogens. Lancet 337, 70–73. 10.1016/0140-6736(91)90735-8 CASPubMedWeb of Science®Google Scholar Munkley, A., Tinsley, C.R., Virji, M. and Heckels, J.E. (1991) Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein. Microbial Pathogenesis 11, 447–452. 10.1016/0882-4010(91)90041-8 CASPubMedWeb of Science®Google Scholar Pettersson, A., Kuipers, B., Pelzer, M., Verhagan, E., Tiesjema, R.H., Tommassen, J. and Poolman, J.T. (1990) Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific. Infection and Immunity 58, 3036–3041. PubMedWeb of Science®Google Scholar Relman, D.A., Domenighini, M., Tuomannen, E., Rappuoli, R. and Falkow, S. (1989) Filamentous haemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proceedings of the National Academy of Science USA 86, 2637–2641. 10.1073/pnas.86.8.2637 CASPubMedWeb of Science®Google Scholar Roberts, M., Fairweather, N.F., Leininger, E., Pickard, D., Hewlett, E.L., Robinson, A., Hayward, C., Dougan, G. and Charles, I.G. (1991) Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P69 outer membrane protein. Molecular Microbiology 5, 1393–1404. 10.1111/j.1365-2958.1991.tb00786.x CASPubMedWeb of Science®Google Scholar Roberts, M., Tite, J.P., Fairweather, N.F., Dougan, G. and Charles, I.G. (1992) Recombinant P69/pertactin: immunogenicity and protection of mice against Bordetella pertussis infection. Vaccine 10, 43–48. 10.1016/0264-410X(92)90418-J CASPubMedWeb of Science®Google Scholar Robinson, A. and Ashworth, L.A.E. (1988) Acellular and defined-component vaccines against pertussis. In Pathogenesis and Immunity in Pertussis ed. A.C. Wardlaw and R. Parton pp. 399–417. Chichester : John Wiley & Sons. Google Scholar Robinson, A., Ashworth, L.A.E. and Irons, L.I. (1989a) Serotyping Bordetella pertussis strains. Vaccine 7, 491–494. 10.1016/0264-410X(89)90270-3 PubMedWeb of Science®Google Scholar Robinson, A., Gorringe, A.R., Funnell, S.G.P. and Fernandez, M. (1989b) Serospecific protection of mice against intranasal infection with Bordetella pertussis. Vaccine 7, 321–324. 10.1016/0264-410X(89)90193-X PubMedWeb of Science®Google Scholar Saukkonen, K., Leinonen, M., Abdillahi, H. and Poolman, J.T. (1989) Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine 7, 325–328. 10.1016/0264-410X(89)90194-1 PubMedWeb of Science®Google Scholar Schryvers, A.B. and Lee, B.G. (1988) Comparative analysis of the transferrin and lactoferrin binding proteins in the family Neisseriaceae. Canadian Journal of Microbiology 35, 409–415. 10.1139/m89-063 Web of Science®Google Scholar Seddon, P.C., Novotny, P., Hart, C.A. and Smith, C.S. (1989) Systemic and mucosal antibody response to Bordetella pertussis antigens in children with whooping cough. Serodiagnosis and Immunotherapy of Infectious Disease 3, 337–343. 10.1016/0888-0786(89)90042-5 Web of Science®Google Scholar Shahin, R.D., Brennan, M.J., Li, Z.M., Meade, B.D. and Manclark, C.R. (1990) Characterization of the protective capacity and immunogenicity of the 69-kDa outer membrane protein of Bordetella pertussis. Journal of Experimental Medicine 171, 63–73. 10.1084/jem.171.1.63 CASPubMedWeb of Science®Google Scholar Stephens, D., Whitney, A.M., Schoolnik, G.K. and Zollinger, W. (1988) Common epitopes of pilin of Neisseria meningitidis. Journal of Infectious Diseases 158, 332–342. 10.1093/infdis/158.2.332 CASPubMedWeb of Science®Google Scholar Stevenson, P., Williams, P. and Griffiths, E. (1991) Common antigenic domains in the transferrin-binding proteins of Neisseria meningitidis, N. gonorrhoae and Haemophilus influenzae. Society for General Microbiology Abstracts Book, 120th Meeting, Nottingham, August 1991, 34. Google Scholar Storsaeter, J. and Olin, P. (1992) Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance. Vaccine 10, 142–144. 10.1016/0264-410X(92)90002-2 CASPubMedGoogle Scholar Thiry, G., Clippe, A., Scarcez, T. and Petre, J. (1989) Cloning of DNA sequenes encoding foreign peptides and their expression in the K88 pili. Applied and Environmental Microbiology 55, 984–993. CASPubMedWeb of Science®Google Scholar Thomas, M.G., Ashworth, L.A.E., Miller, E. and Lambert, H.P. (1989) Serum IgG, IgA and IgM responses to pertussis toxin, filamentous haemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. Journal of Infectious Diseases 160, 838–345. 10.1093/infdis/160.5.838 CASPubMedWeb of Science®Google Scholar Tinsley, C.R. and Heckels, J.E. (1986) Variation in the expression of pili and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection. Journal of General Microbiology 132, 2483–2490. CASPubMedWeb of Science®Google Scholar Tommassen, J., Vermeij, P., Struyve, M., Benz, R. and Poolman, J.T. (1990) Isolation of Neisseria meningitidis mutants deficient in class 1 (PorA) and Class 3 (PorB) outer membrane proteins. Infection and Immunity 58, 1355–1359. CASPubMedWeb of Science®Google Scholar Tsai, C.-M., Frasch, C.E. and Mocca, L.F. (1981) Five structural classes of major outer membrane proteins in Neisseria meningitidis. Journal of Bacteriology 146, 69–78. CASPubMedWeb of Science®Google Scholar van der Ley, P., Heckels, J.E., Virji, M., Hoogerhout, P. and Poolman, J.T. (1991) Topology of outer membrane porins in pathogenic Neisseria spp. Infection and Immunity 59, 2963–2971. PubMedWeb of Science®Google Scholar Verheul, A.F.M., Boons, G.J.P.H., van der Marel, G.A., van Boom, J.H., Jennings, H.J., Snippe, H., Verhoef, J., Hoogerhout, P. and Poolman, J.T. (1991) Minimum oligosaccharide structures required for induction of immune response against meningococcal immunotype L1, L2 and L,3,7,9, lipopolysaccharide determined using synthetic oligosaccharide—prorein conjugates. Infection and Immunity 59, 3566–3573. CASPubMedWeb of Science®Google Scholar Williams, P. (1988) Role of cell envelope in bacterial adaptation to growth in vivo in infections. Biochimie 70, 987–1011. 10.1016/0300-9084(88)90263-5 CASPubMedWeb of Science®Google Scholar Woods, J.P. and Cannon, J.G. (1990) Variation in expression of Class 1 and Class 5 outer membrane proteins during naso-pharyngeal carriage of Neisseria meningitidis. Infection and Immunity 58, 569–572. CASPubMedWeb of Science®Google Scholar Zollinger, W.E. (1990) New and improved vaccines against meningococcal disease. In New Generation Vaccines ed. G.C. Woodrow and M.M. Levine pp. 325–345. New York : Marcel Dekker. Google Scholar Citing Literature Volume74, IssueS22June 1993Pages 43S-51S ReferencesRelatedInformation
Referência(s)